Metadata
Author: Literature
Data
English[en]
The treatment of choice consists of a tyrosine kinase inhibitor targeting the aberrantly active abl kinase.
Spanish[es]
El tratamiento más indicado comprende un inhibidor de tirosina cinasa que actúe en la cinasa abl aberrantemente activa.